Search Results

Paediatric Strategy Forum for medicinal product development of epigenetic modifiers for children: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.

• Authors : Pearson, Andrew DJ.; Stegmaier, Kimberly; Bourdeaut, Franck

• Source: European Journal of Cancer (EUR J CANCER), Nov2020; 139: 135-148. (14p)

Record details

Bromodomain and extra-terminal inhibitors—A consensus prioritisation after the Paediatric Strategy Forum for medicinal product development of epigenetic modifiers in children—ACCELERATE

• Authors : Pearson, Andrew DJ. ^{a, ∗}; DuBois, Steven G. ^b; Buenger, Vickie ^c

• Source: In European Journal of Cancer March 2021 146:115-124

Record details

Factors associated with recurrence and survival length following relapse in patients with neuroblastoma.

• Authors : Basta, Nermine O; Halliday, Gail C; Makin, Guy

• Source: British Journal of Cancer (BR J CANCER), 10/25/2016; 115(9): 1048-1057. (10p)

Record details

10-year report on the European Paediatric Regulation and its impact on new drugs for children's cancers.

• Authors : Pearson, Andrew Dj; Heenen, Delphine; Kearns, Pamela R

• Source: Lancet Oncology (LANCET ONCOL), Mar2018; 19(3): 285-287. (3p)

Record details

High-dose rapid and standard induction chemotherapy for patients aged over 1 year with stage 4 neuroblastoma: a randomised trial

• Authors : Pearson, Andrew DJ ^{a, *}; Pinkerton, C Ross ^b; Lewis, Ian J ^c

• Source: In Lancet Oncology 2008 9(3):247-256

Record details

Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

• Authors : Moreno, Lucas; Caron, Hubert; Geoerger, Birgit

• Source: Expert Opinion on Drug Discovery; August 2017, Vol. 12 Issue: 8 p801-811, 11p

Record details

Targeted approaches to childhood cancer: progress in drug discovery and development

• Authors : Hirsch, Steffen; Marshall, Lynley V; Carceller Lechon, Fernando

• Source: Expert Opinion on Drug Discovery; May 2015, Vol. 10 Issue: 5 p483-495, 13p

Record details

Children’s clinical cancer trials: what needs to change to allow children access to new cancer drugs?

• Authors : Moreno, Lucas; Pearson, Andrew DJ

Subjects: CLINICAL trials; CHILDHOOD cancer; PHARMACEUTICAL industry

• Source: Expert Review of Clinical Pharmacology; Nov2015, Vol. 8 Issue 6, p665-667, 3p

Record details

How can attrition rates be reduced in cancer drug discovery?

• Authors : Moreno, Lucas; Pearson, Andrew DJ

• Source: Expert Opinion on Drug Discovery; April 2013, Vol. 8 Issue: 4 p363-368, 6p

Record details

OPEC/OJEC for stage 4 neuroblastoma in children over 1 year of age.

• Authors : Tweddle, Deborah A.; Pinkerton, C. Ross; Lewis, Ian J.

• Source: Medical & Pediatric Oncology; 2001, Vol. 36 Issue 1, p239-242, 4p

Record details